Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival

[1]  M. Tallman,et al.  Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study. , 2007 .

[2]  N. Heerema,et al.  Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031. , 2007 .

[3]  J. Klein,et al.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.

[4]  J. Radich,et al.  Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. , 2007, Blood.

[5]  J. Cayuela,et al.  Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study , 2006 .

[6]  E. Mejstrikova,et al.  Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.

[7]  H. Kantarjian,et al.  Congestive heart failure is a rare event in patients receiving imatinib therapy. , 2006, Blood.

[8]  Brian Walters,et al.  Cardiotoxicity of the cancer therapeutic agent imatinib mesylate , 2006, Nature Medicine.

[9]  T. Naoe,et al.  High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Pui,et al.  Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.

[11]  Yoo-Jin Kim,et al.  The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2005, Blood.

[12]  M. Schilham,et al.  Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia , 2003, British journal of haematology.

[13]  S. Sohn,et al.  Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration , 2003, British journal of haematology.

[14]  N. Kröger,et al.  Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias , 2003, Leukemia.

[15]  M. Gobbi,et al.  Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse , 2002, Bone Marrow Transplantation.

[16]  H. Gschaidmeier,et al.  Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT) , 2002, Leukemia.

[17]  R. Larson,et al.  Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. , 2002, Blood.

[18]  D. Weisdorf,et al.  Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997 , 2001, Bone Marrow Transplantation.

[19]  N. Schmitz,et al.  Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). , 2000, Blood.

[20]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[21]  M. Amylon,et al.  Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission , 1999, Leukemia.

[22]  N. Heerema,et al.  Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies , 1998, Cancer.

[23]  S. Raimondi,et al.  Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts , 1997, Leukemia.

[24]  N. Chao,et al.  Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia [letter] , 1995 .

[25]  M. Horowitz,et al.  Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1992, Blood.

[26]  M. O'donnell,et al.  Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. , 1991, Blood.

[27]  J. Fletcher,et al.  Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. , 1991, Blood.

[28]  S. Iacobelli,et al.  Design and Methods , 2022 .

[29]  Mark L. Greenberg,et al.  Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia , 2004, Bone Marrow Transplantation.

[30]  M. Labopin,et al.  Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow , 2003, Bone Marrow Transplantation.

[31]  C. Pui,et al.  Acute lymphoblastic leukemia. , 1998, The New England journal of medicine.

[32]  N. Chao,et al.  Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1995, Blood.

[33]  S. Proctor.  Allogeneic bone marrow transplantation. , 1994, Transplant immunology.